Three-dimensional finite element analysis of fixed complete-arch prostheses supported by 4 immediate-loaded implants in the completely edentulous maxilla using clinical computerized tomography data.

Mechanical simulation by loading an occlusal force (load), assumed to be that loaded under clinical conditions, was performed in a computerized tomography (CT) data-based immediate-loaded implant placement simulation. Stresses on and displacements of the implants and surrounding bone tissue were analyzed mechanically using 3-dimensional finite element analysis (FEA). The purpose of this study was to investigate the possibility of practical preoperative design and its evaluation and to assess the effects of connected fixation. Implants with a diameter of 4.0 mm were placed in the bilateral upper incisor and second premolar regions in a 69-year-old woman. An X-ray CT of the head was carried out, and implant placement simulation and 3-dimensional FEA models were constructed from the CT data. Forces were loaded on 4 individual implants placed in this model or all connected implants, and a mechanical analysis was performed. A 100-N vertical force was loaded on each implant as individual loading for the control group, and a 400-N vertical force was loaded on the connected implants as connected loading for the test group. The displacement and stress distributions were assessed using the 3-dimensional FEA. In the test group, established on the assumption of connected fixation for provisional restoration facilitating immediate loading, the maximum stress and displacement of peri-implant bone were smaller than those in the control group undergoing individual loading. The implant displacement level was suggested to serve as a numerical prognostic index of osseointegration of immediate-loaded implants. This method was shown to be immediately applicable to implant placement simulations using CT data currently generated in clinical practice, with no modification. Such a mechanical assessment using the FEA model can be performed noninvasively.

Trimidox induces apoptosis via cytochrome c release in NALM-6 human B cell leukaemia cells.

Trimidox (3,4,5-trihydroxybenzamidoxime) has been shown to reduce the activity of ribonucleotide reductase accompanied by growth inhibition and the differentiation of mammalian cells. Here we examine the induction of apoptosis by trimidox in several human leukaemia cell lines, focusing on the release of cytochrome c and the activation of caspase proteases in the human B cell line NALM-6. Induction of apoptosis by trimidox (300 microM) was detected in NALM-6, HL-60 (premyelocytic leukaemia cells), MOLT-4 (an acute lymphoblastic leukaemia cells), Jurkat (a T-cell leukaemia cells), U937 (expressing many monocyte-like characteristics), and K562 (erythroleukaemia). NALM-6 was most affected by trimidox among leukaemia cells; therefore, we employed NALM-6 cells in the subsequent experiments. The cells showed a time-dependent increase in DNA damage after trimidox (250 microM) treatment. A significant increase in the amount of cytochrome c release was detected after treatment with trimidox. Bcl-2 and Bax protein expressions were not changed by trimidox. Caspase-3 and -9 were activated by incubation with trimidox, whereas caspase-8 was not. Furthermore, trimidox-induced apoptosis was prevented by a broad-spectrum caspase inhibitor, a caspase-3, and a caspase-9 inhibitor, but not by a caspase-8 inhibitor. Inhibition of c-Jun NH2-terminal kinase (JNK) by SP600125 appreciably protected cells from trimidox-induced apoptosis, but no effect inhibition of p38 mitogen-activated protein kinase (MAPK) by SB203580. In contrast, extracellular signal-regulated kinase (ERK) inhibitors U0126 and PD98059 strongly potentiated the apoptotic effect of trimidox. This report shows that the induction of apoptosis by trimidox occurs through a cytochrome c-dependent pathway, which sequentially activates caspase-3 and caspase-9.

Preoperative assessment of treatment planning on minimization of micro-movement during healing period of immediate-loaded implants using X-ray CT data-based simulation.

Abstract The purpose of this study was to investigate the possibility of practical preoperative design and its evaluation and to assess the effects of connected fixation on minimization of micro movement during healing period of immediately loaded implants.Mechanical simulation by loading an occlusal force (load), assumed to be that loaded under clinical conditions, was performed in a computed tomography (CT) data-based immediate-loaded implant placement simulation. Stresses on and displacements of the implants and surrounding bone tissue were analyzed mechanically using three-dimensional finite element analysis.An X-ray CT of the head was carried out, and implant placement simulation andthree-dimensional finite element analysis models were constructed from the CT data. Forces were loaded on four individual implants placed in this model or all connected implants, and a mechanical analysis was performed. A 100 N vertical force was loaded on each implant as individual loading for the control group, and a 400 N vertical force was loaded on the connected implants as connected loading for the test group. The displacement and stress distributions were assessed using the three-dimensional finite element analysis. In the test group, established on the assumption of connected fixation for provisional restoration facilitating immediate loading, the maximum stress and displacement of peri-implant bone were smaller than those in the control group undergoing individual loading.The implant displacement level was suggested to serve as a numerical prognostic index of osseointegration of immediate-loaded implants. This method was shown to be immediately applicable to implant placement simulations using CT data currently generated in clinical practice, with no modification. Such a mechanical assessment using the finite element analysis model can be performed noninvasively.

Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice.

We have investigated the effect of naringenin (NGEN) on tumor growth in various human cancer cell lines and sarcoma S-180-implanted mice. NGEN showed cytotoxicity in cell lines derived from cancer of the breast (MCF-7, MDA-MB-231), stomach (KATOIII, MKN-7), liver (HepG2, Hep3B, Huh7), cervix (Hela, Hela-TG), pancreas (PK-1), and colon (Caco-2) as well as leukemia (HL-60, NALM-6, Jurkat, U937). NGEN-induced cytotoxicity was low in Caco-2 and high in leukemia cells compared to other cell lines. NGEN dose-dependently induced apoptosis, with hypodiploid cells detected in both Caco-2 and HL-60 by flow cytometric analysis. In vivo, NGEN inhibited tumor growth in sarcoma S-180-implanted mice, following intraperitoneal or peroral injection once a day for 5 d. Naringin (NG) also inhibited tumor growth by peroral injection but not intraperitoneal injection. NGEN, one of the most abundant flavonoids in citrus fruits, may have a potentially useful inhibitory effect on tumor growth.

Octylcaffeate induced apoptosis in human leukemia U937 cells.

We found that octylcaffeate, a semisynthetic caffeic acid derivative, strongly inhibited the growth of human histiolytic lymphoma U937 cells in a dose- and time-dependent manner via apoptosis. Octylcaffeate induced the fragmentation of DNA into multiples of 180 bp (an apoptotic DNA ladder) and condensation of chromatin, and increased the percentage of hypodiploid cells detected with a flow cytometer. DNA fragmentation induced by octylcaffeate was inhibited by pretreatment with Z-DEVD-FMK and Z-Asp-CH(2)D-CB, an inhibitor of caspase, clearly showing that the mode of cell death is apoptotic. These findings suggest that the cytotoxicity of octylcaffeate involves the induction of apoptosis.